March 21, 2013
/EIN Presswire/ -- Cambridge Healthtech Institute's
Insight Pharma Reports Affiliated Reports Collection announces the addition of the following reports to the Affiliated Reports Collection:
Autoimmune Disorders-Pipeline Review, H1 2013
Liver Cancer -Pipeline Review, H1 2013
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies
Alzheimer's Disease Partnering 2007-2013
Bigpharma Partnering Yearbook 2013 January 2013
Bigbiotech Partnering Yearbook 2013 January 2013
Pharmaceutical Partnering Yearbook 2013 January 2013
Biotechnology Partnering Yearbook 2013 January 2013
Toll-Like Receptor (TLR) Agonists & Antagonists
Therapy Trends: Hepatitis C-KOL Insight Module
Antibody Partnering Terms and Agreements
Drug Delivery Partnering Terms and Agreements
Cancer Vaccine Partnering Agreements
Biomarkers in Drug Discovery
Bioinformatics Partnering Terms & Agreements
Biomarker Partnering Terms & Agreements
Companion Diagnostics Partnering Terms and Agreements
Personalized Medicine Partnering Terms and Agreements
Diagnostics Partnering Terms and Agreements
Diabetic Neuropathy - Pipeline Review
2012 CRO Quality Benchmarking
Metabolic Partnering Terms and
Immunology Partnering Terms and Agreements
Mucositis Partnering 2007-2012
Inflammatory Partnering 2007-2012
Systemic Lupus Partnering 2007-2012
Biodefense Industry - Market to Benefit from Federal Funding
Read more about these report online at:
http://www.insightpharmareports.com/Reports/All.aspx
For more information and to purchase, visit:
http://www.InsightPharmaReports.com or contact Kerri Simpson at
ksimpson@healthtech.com or 781-972-1347.
About Insight Pharma Reports
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute.
http://www.InsightPharmaReports.com
Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit
http://www.insightpharmareports.com/affiliatedreports/# # #
Read more Press Releases by EIN Presswire:
